Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

GSK’s Tyverb cleared for use alongside Herceptin

Combination already approved in the Philippines, Russia and Thailand

- PMLiVE

Shoot the messenger: changing behaviours by marketing to the subconscious

How the perception of a message can change depending on who delivers it

- PMLiVE

New global head of HR for Dr Reddy’s

Sripada Chandrasekhar joins from IBM

- PMLiVE

Shires’s Jeffrey Jonas to lead Sage

CNS appoints CEO alongside new CMO and CFO

- PMLiVE

Pfizer faces NICE rejection for lung cancer drug

Xalkori not cost-effective use of NHS resources in England and Wales

- PMLiVE

MannKind celebrates as inhaled insulin clears pivotal trials

Closing in on approval of Afrezza

China flag thumb

China’s bribery probe goes national

Expands investigation that already affects GSK, Sanofi, Lilly, AZ, Lundbeck, Novo and UCB

- PMLiVE

Forest and Almirall delay FDA filing of COPD drug

Puts companies behind in LAMA/ LABA combination race

- PMLiVE

Curis looks to MedImmune and Takeda for new hires

Tania Chander and Jaye Viner join cancer specialist

- PMLiVE

Networks in Health expands into Italy

Online doctors community partners with Merqurio

ABPI London offices

ABPI toolkit to help pharma companies disclose trial data

Aims to improve transparency efforts in UK

- PMLiVE

Lilly buoyant as lung cancer hope clears pivotal study

Necitumumab on course for regulatory submission in 2014

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links